Ethics approval and consent to participate
The study Radiomic-TBI involving human participants was reviewed and approved by the French institution Comité de protection des personnes (Radiomic-TBI cohort; NCT04058379, first posted: 15 august 2019). Informed consent was obtained from all subjects and/or their legal guardian(s). The study RadioxyTC was also allowed by the French Direction de la Recherche Clinique et de l’Innovation and registered on the Health Data Hub (Radioxy-TC cohort; Health Data Hub index F20220207212747, first posted: 7 February 2022). Patients were individually informed, but no written informed consent was required, although patients had the opportunity to decline their participation in the study. These studies were carried out in accordance with the french regulation.